A citation-based method for searching scientific literature

Annette Haacke, Sarah A Broadley, Raina Boteva, Nikolay Tzvetkov, F Ulrich Hartl, Peter Breuer. Hum Mol Genet 2006
Times Cited: 93



Laura Masino, Valeria Musi, Rajesh P Menon, Paola Fusi, Geoff Kelly, Thomas A Frenkiel, Yvon Trottier, Annalisa Pastore. FEBS Lett 2003
Times Cited: 90




List of shared articles



Times cited


Conformational diseases: structural studies of aggregation of polyglutamine proteins.
Elena Papaleo, Gaetano Invernizzi. Curr Comput Aided Drug Des 2011
10

Ataxin-3 is subject to autolytic cleavage.
Pier Luigi Mauri, Matteo Riva, Daniela Ambu, Antonella De Palma, Francesco Secundo, Louise Benazzi, Marco Valtorta, Paolo Tortora, Paola Fusi. FEBS J 2006
22


CK2 and GSK3 phosphorylation on S29 controls wild-type ATXN3 nuclear uptake.
V Pastori, E Sangalli, P Coccetti, C Pozzi, S Nonnis, G Tedeschi, P Fusi. Biochim Biophys Acta 2010
15


Toward understanding Machado-Joseph disease.
Maria do Carmo Costa, Henry L Paulson. Prog Neurobiol 2012
157

Study of subcellular localization and proteolysis of ataxin-3.
Chiara Pozzi, Marco Valtorta, Gabriella Tedeschi, Elena Galbusera, Valentina Pastori, Alessandra Bigi, Simona Nonnis, Eleonora Grassi, Paola Fusi. Neurobiol Dis 2008
44

Conformational behavior and aggregation of ataxin-3 in SDS.
Helen M Saunders, Victoria A Hughes, Roberto Cappai, Stephen P Bottomley. PLoS One 2013
6


Polyglutamine diseases: the special case of ataxin-3 and Machado-Joseph disease.
Carlos A Matos, Sandra de Macedo-Ribeiro, Ana Luísa Carvalho. Prog Neurobiol 2011
89

Molecular Mechanisms and Cellular Pathways Implicated in Machado-Joseph Disease Pathogenesis.
Clévio Nóbrega, Ana Teresa Simões, Joana Duarte-Neves, Sónia Duarte, Ana Vasconcelos-Ferreira, Janete Cunha-Santos, Dina Pereira, Magda Santana, Cláudia Cavadas, Luís Pereira de Almeida. Adv Exp Med Biol 2018
9

SCA3: neurological features, pathogenesis and animal models.
Olaf Riess, Udo Rüb, Annalisa Pastore, Peter Bauer, Ludger Schöls. Cerebellum 2008
148


Proteolytic Cleavage of Polyglutamine Disease-Causing Proteins: Revisiting the Toxic Fragment Hypothesis.
Carlos A Matos, Luis Pereira de Almeida, Clevio Nobrega. Curr Pharm Des 2017
16